Annual report pursuant to Section 13 and 15(d)

ORGANIZATION AND BASIS OF PRESENTATION (Details Narrative)

v3.19.2
ORGANIZATION AND BASIS OF PRESENTATION (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Jan. 31, 2019
Mar. 31, 2019
Mar. 31, 2018
State of incorporation   Nevada  
Date of incorporation   Feb. 21, 2014  
Issuance of common stock for cash   $ 75,000 $ 795,000
Net loss   (2,679,022) (2,386,864)
Net cash used in operating activities   (905,051) (673,467)
Working capital deficit   $ (19,807)  
Shares issued   37,500  
Shares issued price per share   $ 2.00  
Proceeds from issuance of common stock   $ 75,000 795,000
Proceeds from issuance of convertible notes   1,529,455
Trace Analytics [Member]      
Common stock purchase agreement, description The Company closed on a purchase of 520,410 shares of common stock of Trace Analytics, Inc., a Washington corporation (“Trace Analytics”), for an aggregate purchase price of $1,250,000, of which $750,000 was paid in cash and $500,000 was paid in shares of common stock of the Company. Trace Analytics is a cannabis testing laboratory. Immediately following the purchase, the Company holds 51% of the issued and outstanding shares of common stock of Trace Analytics.    
Issuance of common stock for cash, shares 520,410    
Issuance of common stock for cash $ 1,250,000    
Private Placements [Member] | Accredited Investors [Member]      
Proceeds from issuance of convertible notes   $ 1,600,000